Vol 3, No 2 (2000)
Review paper
Submitted: 2012-01-23
Published online: 2003-05-27
Nuclear medicine in the post-genomic era
John Buscombe
Nucl. Med. Rev 2000;3(2):177-186.
Vol 3, No 2 (2000)
Reviews
Submitted: 2012-01-23
Published online: 2003-05-27
Abstract
The underlying precepts by which medicine operates will be
changed forever by the elucidation of the human genomic sequence.
The possibility of using limited forms of genetic engineering
are present and beset by ethical considerations. However
the use of genetic material in both aiding diagnosing disease
and helping our understanding of disease processes is
being rapidly diffused into clinical medicine. As the only method
available for the study of function in vivo, Nuclear Medicine
is ideally suited to act as a bridge between the work in the biotechnology
laboratory and the patient.
This short review will look at some of the issues raised by the this
new horizon in medicine and how it will impact on our practice
Abstract
The underlying precepts by which medicine operates will be
changed forever by the elucidation of the human genomic sequence.
The possibility of using limited forms of genetic engineering
are present and beset by ethical considerations. However
the use of genetic material in both aiding diagnosing disease
and helping our understanding of disease processes is
being rapidly diffused into clinical medicine. As the only method
available for the study of function in vivo, Nuclear Medicine
is ideally suited to act as a bridge between the work in the biotechnology
laboratory and the patient.
This short review will look at some of the issues raised by the this
new horizon in medicine and how it will impact on our practice
Keywords
genome; nuclear medicine; future prospects
Title
Nuclear medicine in the post-genomic era
Journal
Nuclear Medicine Review
Issue
Vol 3, No 2 (2000)
Article type
Review paper
Pages
177-186
Published online
2003-05-27
Page views
462
Bibliographic record
Nucl. Med. Rev 2000;3(2):177-186.
Keywords
genome
nuclear medicine
future prospects
About this article